Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction

BACKGROUND AND AIMS: Sodium–glucose linked cotransporter-2 (SGLT2) inhibitors reduce the likelihood of hospitalization for heart failure and cardiovascular death in both diabetic and non-diabetic individuals with reduced ejection fraction heart failure. Because SGLT2 inhibitors lead to volume contra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Connelly, Kim A., Zhang, Yanling, Desjardins, Jean-François, Nghiem, Linda, Visram, Aylin, Batchu, Sri N., Yerra, Verra G., Kabir, Golam, Thai, Kerri, Advani, Andrew, Gilbert, Richard E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007658/
https://ncbi.nlm.nih.gov/pubmed/32035482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-0994-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados